Lenalidomide following whole-brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy.
Br J Haematol
; 201(1): 150-153, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36682363
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Central Nervous System Neoplasms
Limits:
Humans
Language:
En
Journal:
Br J Haematol
Year:
2023
Document type:
Article
Affiliation country:
India